Assessing association between biomarkers and clinical outcomes–moving beyond p -values

Understanding the relationship between biomarkers and clinical outcomes is essential in medical research. Although regression models are used to quantify these associations, translating statistical findings into clinical practice remains challenging. Standard practice often reduces assessment to a p-value threshold, labelling a biomarker an ‘independent’ predictor if it passes. This oversimplification obscures nuanced interactions: different modelling strategies can yield divergent interpretations, and results may misrepresent clinical relevance. Large studies may highlight statistically significant but clinically trivial biomarkers, while smaller studies may miss important predictors due to limited power. Moreover, regression coefficients – especially from nonlinear models – often fail to convey the magnitude of association in a clinically intuitive way. Using trial data, our paper examines these limitations and reframes association analysis as a step towards addressing clinical questions: When, and to what extent, does a biomarker improve outcome prediction? We propose that an incremental predictability measure provides a more clinically relevant and interpretable way to quantify biomarker–outcome associations. Our findings underscore the need for analytic approaches that move beyond statistical significance towards measures that reflect clinical value. By emphasizing predictive performance, we aim to improve the translation of statistical associations into actionable insights and support more accurate identification of biomarkers that matter for patient outcomes.

Authors

Institutions

Publication Details

Journal
Statistical Theory and Related Fields
Published
2026-11-17
DOI
https://doi.org/10.1080/24754269.2026.2763239
Primary Topic
Statistical Methods in Epidemiology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Assessing association between biomarkers and clinical outcomes–moving beyond p -values

Daniel A. Paydarfar, Brian Lee Claggett, Mitchell A. Psotka, Scott Solomon et al.
1 links
Statistical Theory and Related Fields
Statistical Methods in Epidemiology
article

Assessing association between biomarkers and clinical outcomes–moving beyond p -values

Daniel A. Paydarfar, Brian Lee Claggett, Mitchell A. Psotka, Scott Solomon, Lu Tian, Ryan Sun, Lee-Jen Wei, Dae Hyun Kim
article en

Abstract

Understanding the relationship between biomarkers and clinical outcomes is essential in medical research. Although regression models are used to quantify these associations, translating statistical findings into clinical practice remains challenging. Standard practice often reduces assessment to a p-value threshold, labelling a biomarker an ‘independent’ predictor if it passes. This oversimplification obscures nuanced interactions: different modelling strategies can yield divergent interpretations, and results may misrepresent clinical relevance. Large studies may highlight statistically significant but clinically trivial biomarkers, while smaller studies may miss important predictors due to limited power. Moreover, regression coefficients – especially from nonlinear models – often fail to convey the magnitude of association in a clinically intuitive way. Using trial data, our paper examines these limitations and reframes association analysis as a step towards addressing clinical questions: When, and to what extent, does a biomarker improve outcome prediction? We propose that an incremental predictability measure provides a more clinically relevant and interpretable way to quantify biomarker–outcome associations. Our findings underscore the need for analytic approaches that move beyond statistical significance towards measures that reflect clinical value. By emphasizing predictive performance, we aim to improve the translation of statistical associations into actionable insights and support more accurate identification of biomarkers that matter for patient outcomes.

Statistical Theory and Related Fields
Inova Health System (US), The University of Texas MD Anderson Cancer Center (US), Harvard University (US), Hebrew SeniorLife (US), Stanford University (US)
Good health and well-being
Statistical Methods in Epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon